Issuer Direct Corporation
| (b) | Address of Issuer’s Principal Executive Offices: |
One Glenwood Avenue, Suite 1001, Raleigh, NC 27603
| (a) | Name of Persons Filing: |
Topline Capital Management, LLC (“TCM”)
Collin McBirney
Topline Capital Partners, LP (“TCP” or the “Fund”)
| (b) | Address of Principal Business Office or, if none, Residence: |
544 Euclid Street, Santa Monica, CA 90402
Reference is made to Row 4 of pages 2—4 of this Schedule 13G (this “Schedule”), which are incorporated by reference herein.
| (d) | Title of Class of Securities: |
Common Stock, $0.001 par value
| (e) | CUSIP Number: 46520M204 |
Item 3. | If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
Reference is hereby made to Rows 5-9 and 11 of pages 2, 3 and 4 of this Schedule, which are incorporated by reference herein.
As of November 14, 2024, the Fund beneficially owns 715,516 shares of the issuer’s common stock.
The securities reported on this Schedule as beneficially owned by TCM (the “Securities”) are held by and for the benefit of the Fund. Under the definition of “beneficial ownership” in Rule 13d-3 under the Act, it is also possible that the individual general partners, executive officers, and members of the foregoing entities might be deemed the “beneficial owners” of some or all of the Securities insofar as they may be deemed to share the power to direct the voting or disposition of such Securities. TCM, as the investment manager and general partner of the Fund, and Collin McBirney, as the member-manager of TCM, may, therefore, be deemed to beneficially own the Securities held by the Fund for the purposes of Rule 13d-3 under the Act insofar as they may be deemed to have the power to direct the voting or disposition of those Securities.
5